Here is some more information concerning the trials in India. Cyrcadia has teamed up with Apollo Hospitals in India. They are a leading care provider in India and also specialize in medical tourism. They are a major player. This is from an overview put out by Cyrcadia Health from May 2015
CH (Cyrcadia Health) initial ASIA market launch through India’s Apollo Hospital will address largest breast cancer epidemic population in the world.A 10,000 patient screening trial is planned with Apollo in H2 2015
Here is a quote from Rob Royea from an interview with Wearable Technologies in March:
We have made excellent progress with Cyrcadia over the past year. We designed a highly scalable, wearable, conformable technology, and have a finalized clinical product released through Flextronics, the largest provider of medical wearable patches globally. Commercial prototypes are in progress as we now enter into our final clinical validation trial here in the US. El Camino Hospital, The Ohio State University and now Stanford’s Canary Center specializing in identifying early biomarkers are all joining in the trial which we expect will begin no later than May and be completed with the first phase of 173 patients by September 2015. Larger screening trials will be conducted at the National University Hospital in Singapore and Through Apollo Medical in India by the end of 2015. Product launch is projected for early 2016 in Asia and Europe with the US to follow later in 2016 post final FDA clearance.
Here is some information on Apollo Hospitals in India:
Apollo presence encompasses over 10,000 beds across 64 hospitals, more than 2200 pharmacies, over 100 primary care & diagnostic clinics, 115 telemedicine units across 9 countries, health insurance services, global projects consultancy, 15 academic institutions and a Research Foundation with a focus on global clinical trials, epidemiological studies, stem-cell and genetic research.
Market Data 
Markets 
AI
